Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Correction In Proceeding Of 35Th Annual General Meeting Held On September 25, 2020

 This is with reference to our letter dated September 25, 2020 regarding submission of Proceedings of 35th Annual General Meeting held on Friday, September 25, 2020 through Video Conferencing/Other Audio-Visual Means ('VC/OAVM'). Please note that the total number of members present during the 35th Annual General Meeting is 85 (Eighty Five) instead of 82 (Eighty Two) which was wrongly entered due to oversight issue. The correct number of members present at the 35th Annual General Meeting is 85 i.e. 83 members attended through VC and 2 members attended in person. You are requested to please take on record the above said correction for your reference and needful.
08-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for all the Designated Persons and their immediate relatives of the Company with effect from Thursday, October 01, 2020 until 48 hours after the announcement of the unaudited financial results of the Company for the quarter and half year ended September 30, 2020. Accordingly, all Designated Persons and their immediate relatives are advised not to trade (buy or sell or pledge etc.) in the securities/shares of the Company during the aforesaid period of closure of Trading Window.
30-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
26-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Outcome Of 35Th Annual General Meeting ('AGM') Of The Company Held Today I.E. 25Th September, 2020 - Re-Classification/Removal Of Names Of Persons Forming Part Of The Promoter Group From 'Promoter & Promoter Group Category' To 'Public Category

 We would like to inform you that, the 35thAnnual General Meeting of the Company was held today i.e. Friday, September 25, 2020 at 09:30 a.m. being requisite quorum present, meeting commenced at 09:30 a.m. through Video Conferencing ('VC')/Other Audio Visual Means ('OVAM') pursuant to General Circular No.14/2020 dated April 08, 2020, General Circular No. 17/2020 dated April 13, 2020 and Circular No. 20/2020 dated May 05, 2020 respectively issued by the Ministry of Corporate Affairs ('MCA Circulars'), Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated May 12, 2020 issued by the Securities and Exchange Board of India ('SEBI Circular') and in compliance with the provisions of the Companies Act, 2013 ('Act') and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). in this regard, please find attached herewith outcome of 35th Annual General Meeting.
25-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Voting Results Of The 35Th Annual General Meeting Of Bliss GVS Pharma Limited Held On September 25, 2020 Along With Scrutinizer'S Report

 In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 35th Annual General Meeting of the Company held on Friday, September 25, 2020 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 35th Annual General Meeting. Please acknowledge and take on record the same.
25-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Proceedings Of 35Th Annual General Meeting Held On September 25, 2020

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 35th Annual General Meeting held on Friday, September 25, 2020 at 9:30 am through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). Kindly take the above intimation in your record.
25-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 We would like to inform you that 35th Annual General Meeting of the Company was held today i.e. Friday, September 25, 2020 at 09:30 a.m., being requisite quorum present, meeting commenced at 09:30 a.m., through Video Conferencing ('VC')/Other Audio Visual Means ('OVAM'), in compliance with the General Circular No.14/2020 dated April 08, 2020, General Circular No. 17/2020 dated April 13, 2020 and Circular No. 20/2020 dated May 5, 2020 respectively issued by the Ministry of Corporate Affairs ('MCA Circulars') and Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated May 12, 2020 issued by the Securities and Exchange Board of India ('SEBI Circular') and in compliance with the provisions of the Companies Act, 2013 ('Act') and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). In this regard, please find attached herewith outcome of 35th Annual General Meeting.
25-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 By Life Insurance Corporation Of India

 With reference to the captioned subject, this is inform you that, the Company has received disclosure w.r.t. acquisition of additional 1,50,000 equity shares by Life Insurance Corporation of India ('LIC') constituting to 0.145% of total share capital of the Company under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. As on September 10, 2020, LIC shareholding in the Company is 52,76,355 constituting to 5.115% of total share capital of the Company. This is for your information and record.
14-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
11-09-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 read with Schedule III Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and in compliance with the General Circular dated May 5, 2020 read with General Circulars dated April 8, 2020 and April 13, 2020 issued by the Ministry of Corporate Affairs and SEBI Circular dated May 12, 2020, we enclosed herewith the clippings of newspaper advertisements of the Notice of 35th Annual General Meeting of the Company to be held on Friday, September 25, 2020, at 09:30 a.m. (IST) through Video Conferencing / Other Audio Visual Means only, E-voting details and Book Closure for the purpose of payment of final dividend to the Members published in Free Press Journal and Navshakti on September 05, 2020. This is for your information and record.
05-09-2020
Next Page
Close

Let's Open Free Demat Account